Molecular Analysis for Precision Oncology Congress 2024

Resources are available according to the presenters' agreement to release them.

• Abstracts, ePosters and Guidelines sessions are open access.
• Slides and webcasts are reserved to ESMO Members and registered Delegates.

The copyright protected educational resources from this event are for personal usage only and not to be shared with any third parties. ESMO thanks the authors for their generosity.

MAP 2024 focused on current and emerging approaches in precision oncology, highlighting successes and challenges while proposing potential solutions in clinical research and practice. It explored the molecular characterization and clonal evolution of solid tumors across cancer populations, as well as emerging technologies like AI for cancer profiling and the mechanisms of tumor growth and metastasis. Additionally, it covered new concepts in molecular tumor classification and the biomarker-driven development of targeted therapeutics, including their methodological and regulatory implications.